Navigation Links
Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update
Date:11/23/2009

duction in Whole Blood and PBMC Cultures" was presented at the Tri-Society Annual Conference 2009 of the Society for Leukocyte Biology, International Cytokine Society, & International Society for Interferon and Cytokine Research, Cellular and Cytokine Interactions in Health and Disease in Lisbon, Portugal, October 18-21, 2009, by authors Gregory B. Pott, K. Scott Beard, and Leland Shapiro, of the Department of Medicine, University of Colorado Denver, Aurora, Colorado and included data of patients with lower extremity diabetic ulcers by Matthew Regulski, Wound Care Center of Ocean County, New Jersey.
  • Dr. Jane Fore MD, FAPWCA, FACCWS, of the Tri-State Wound Care and Hyperbaric Center in Clarkston, WA, presented the results of her clinical study that showed that the use of hydrolyzed collagen (CellerateRx) increased the efficiency of healing in skin tears/flaps at the 24th Annual Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing, on October 22 in San Antonio.
  • The Company participated in the Save A Leg, Save a Life Foundation National Conference (SALSAL) in Orlando on October 8th.
  • The Company exhibit at the Georgetown University Hospital's Team Approach to Diabetic Limb Salvage (DLS) conference in Washington, D.C. on September 24th-26th. CellerateRx®, was featured in an abstract by Dr. Matthew Regulski, DPM, Director of the Wound Care Center of Ocean County, NJ. The abstract, "Activated Collagen: An Evidence Based Study in Human Leg Ulcers", provides data showing that all activated collagen treated wounds were healed by five weeks, while the control wounds were approximately 80% healed within twelve weeks.

Acquisitions

The Company has completed acquisitions that have enhanced the current and future fundamental value of the Company. Below is a list of a few of the acquisitions that have been announced and are in the
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Reportlinker Adds The Future of the Wound Care Management Market to 2015
2. Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings
3. Tamaulipas Comparative Wound Healing Test Treatment Successfully Concluded
4. Wound Management Technologies (OTCBB- WNDM) Signs Biotech Agreement With Biocure S.r.l. of Milan, Italy
5. Derma Sciences Announces Multiple Clinical Presentations of MEDIHONEY(R) at Upcoming Major Wound Care Conference
6. Wound Management to Participate at Save A Leg, Save a Life Foundation National Conference
7. Wound Management Technologies Acquires Resorbable Orthopedics
8. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
9. New Data Supports ConvaTec Negative Pressure Wound Therapy
10. New Powder Speeds Healing of Difficult Foot Wounds
11. Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Germany und LONDON ... , Ziel der Zusammenarbeit sind ... genomischer Daten aus Plasmaproben zur Steuerung von Therapien ... werden kann  Neuer Bluttest basiert auf ... und soll auf Rotor-Gene Q, einer Automationsplattform der ...
(Date:7/28/2014)... and LONDON , July 28, 2014 ... to create and commercialize companion diagnostic using genomic data ...  for non-small cell lung cancer patients  New ... test and is planned to run on Rotor-Gene Q, member of ... enabled by AstraZeneca master framework agreement adds to QIAGEN,s ...
(Date:7/28/2014)... 2014 CTI BioPharma Corp. (CTI) (NASDAQ and ... second quarter 2014 financial results on Monday, August 4, ... Following the announcement, members of the management team will ... and provide a general corporate update at 4:30 p.m. ... be obtained as follows: Monday, August 4 ...
Breaking Medicine Technology:QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 2QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 3QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 4QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 5QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 6QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 7QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014 2
...   New product launches are continually occurring across various ... to balance the dueling goals of containing costs and producing ... determining how much to invest, and how to best spend ... primary care launch is spent before during the launch ...
... this week,s 46th Annual Midyear Clinical Meeting and Exhibition ... Health launched BarCode360™ , a solution that supports ... timely and cost efficient to order medications and ensure ... bedside. ASHP has set a goal for ...
Cached Medicine Technology:Launch Spend Insights: Companies Now Invest More in Launch Year Than in Previous 3 Ramp-Up Years Combined 2Cardinal Health Launches Innovative Barcode Administration Solution to Help Hospitals Bridge Gaps in Medication Safety 2Cardinal Health Launches Innovative Barcode Administration Solution to Help Hospitals Bridge Gaps in Medication Safety 3
(Date:7/28/2014)... WA (PRWEB) July 28, 2014 According to ... Vkool.com, this is a comprehensive fitness guide that teaches men ... per week. , Vkool reveals in its review that ... discover:, Ways to gain the maximum ... to build muscle and avoid fat gain , ...
(Date:7/28/2014)... July 28, 2014 TherapySites, ... health professionals, announced today its affiliation with the ... This new relationship allows TherapySites to continue to extend ... benefits and promotional offers. , “There has been a ... today. With nearly 3 billion Internet users, it ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 CW4K was ... First Lady Michelle Obama and Partnership for a ... as they join the group's DrinkUP effort, ... water, more often. , The seven organizations added ... Nalgene® Outdoor Products, S’well Bottle, Santa Clara Valley Water ...
(Date:7/28/2014)... July 28, 2014 Footwear etc. is ... styles from Mephisto. With shoes, sandals, and boots that ... products continually provide handmade comfort shoes and ... women have come to rely on the superb value, ... Mephisto shoes and sandals contain the highest quality materials ...
(Date:7/28/2014)... Washington, DC (PRWEB) July 28, 2014 ... beyond, many are looking to private exchanges. “Private ... the August 6 webinar from Atlantic Information Services, will ... insurers’ private exchange strategies for the future. , Barbara ... from PwC with extensive experience in the private exchange ...
Breaking Medicine News(10 mins):Health News:Greek God Muscle Building Program Review Exposes Greg O’Gallagher's Muscle Building Guide for Men – Vkool.com 2Health News:Greek God Muscle Building Program Review Exposes Greg O’Gallagher's Muscle Building Guide for Men – Vkool.com 3Health News:TherapySites (Websites for Therapists) Partners with the Illinois Association for Marriage and Family Therapy 2Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 2Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 3Health News:Footwear etc. Highlights Phenomenal Models of Mephisto Shoes 2Health News:Footwear etc. Highlights Phenomenal Models of Mephisto Shoes 3Health News:Three PwC Consultants to Offer Insurers Successful Strategies for Private Exchanges 2
... Automates IBC Protocol Operations and Addresses Medical Research Compliance ... TOPAZ Technologies, a leading provider of medical research management ... latest software addition to its product line, the Biosafety ... the medical research study protocol process, from protocol inception ...
... still needs doctors, interpretation, , , WEDNESDAY, June 10 ... ability -- and which you can give yourself -- ... tests in detecting early dementia, according to British researchers. ... "shows great promise as a screening test for Alzheimer,s ...
... DALLAS, June 10 When he arrived at Methodist Rehabilitation ... by Guillain-Barre Syndrome and barely able to lift his head. ... therapist and the rehabilitation staff, the 48-year-old father of two ... a walker. "My son said that all he wanted for ...
... Biology of Bavituximab and Chemotherapy in Lung Cancer Awarded to ... , - New Study Complements Ongoing Bavituximab Plus Carboplatin/Paclitaxel ... - , , TUSTIN, Calif., June 10 Peregrine ... the ASCO Research Foundation has awarded one of its 2009 ...
... Exclusive Worldwide License to Transdel,s Anti-Cellulite Cosmeceutical Product ... Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP) ... licensing agreement providing JH Direct with the exclusive ... utilizes Transdel,s patented transdermal delivery system technology, Transdel(TM). ...
... , LOS ALTOS, Calif., June 10 InteKrin Therapeutics ... American Diabetes Association annual meeting in New Orleans demonstrating ... anti-diabetic efficacy consistent with maximal dose thiazolidinedione (TZD) therapy ... , The 4 week double blind placebo controlled ...
Cached Medicine News:Health News:TOPAZ Technologies Introduces Biosafety Software Solution 2Health News:TOPAZ Technologies Introduces Biosafety Software Solution 3Health News:Questionnaire May Help Spot Early Dementia 2Health News:Questionnaire May Help Spot Early Dementia 3Health News:Former Quadriplegic Patient Able to Walk Out of Methodist Rehabilitation Hospital 2Health News:ASCO Research Foundation Grant Will Support Study of Peregrine's Bavituximab in Lung Cancer 2Health News:ASCO Research Foundation Grant Will Support Study of Peregrine's Bavituximab in Lung Cancer 3Health News:ASCO Research Foundation Grant Will Support Study of Peregrine's Bavituximab in Lung Cancer 4Health News:Transdel Pharmaceuticals Enters Into License Agreement with JH Direct, LLC for Cosmeceutical Product 2Health News:Transdel Pharmaceuticals Enters Into License Agreement with JH Direct, LLC for Cosmeceutical Product 3Health News:Transdel Pharmaceuticals Enters Into License Agreement with JH Direct, LLC for Cosmeceutical Product 4Health News:InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeting 2Health News:InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeting 3
Liquichek Blood Gas Plus E Control is an aqueous product used to monitor the measurement of pH, pCO2, pO2 and electrolytes. Available in four levels....
Liquichek CK/LD Isoenzyme Control features analytes used in cardiac profile testing and protein electrophoresis. Assayed for most methods including instruments, immunoinhibition kits and electrophore...
Meter Trax Control is a whole blood quality control that can be used for glucose, hemoglobin and hematocrit testing on point of care instruments....
Lyphochek® Hemoglobin A1C Linearity Set is a human whole blood based product designed to verify linearity throughout the patient reportable range of hemoglobin A1C assays....
Medicine Products: